Catalyst Pharmaceuticals (CPRX) Revenue Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 20.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.51% |
| Dec 31, 2025 | 35.94% |
| Sep 30, 2025 | 37.37% |
| Jun 30, 2025 | 40.26% |
| Mar 31, 2025 | 48.61% |
| Dec 31, 2024 | 54.70% |
| Sep 30, 2024 | 52.97% |
| Jun 30, 2024 | 49.99% |
| Mar 31, 2024 | 48.30% |
| Dec 31, 2023 | 52.76% |
| Sep 30, 2023 | 51.87% |
| Jun 30, 2023 | 49.83% |
| Mar 31, 2023 | 43.09% |
| Dec 31, 2022 | 26.35% |
| Sep 30, 2022 | 22.82% |
| Jun 30, 2022 | 22.58% |
| Mar 31, 2022 | 51.27% |
| Dec 31, 2021 | 324.73% |